# Vim

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vim

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.getvim.com
- Total disclosed funding: $60M
- Latest round: Series C (Jul 1, 2021)
- Investors on record: 8

## About

Founded in 2015 by co-founders Asaf David, Oron Afek, and Yael Peled and based in California, US, Vim, Inc., formerly known as BookMD, Inc., provides a platform that enables seamless data exchange and workflow integration between healthcare providers, payers, and other stakeholders to improve provider experience and streamline the deployment of applications in the healthcare environment. In May 2021, Vim, Inc. raised USD 35 million in Series B funding led by investors Walgreens Boots Alliance Inc. and Anthem, with participation from another investor, Frist Cressey Ventures. The funding was part of a larger USD 60 million series B funding.


Vim offers a middleware platform, Vim Connect, to facilitate data exchange and workflow integration within the healthcare ecosystem. The technology enables seamless integration with various electronic health record (EHR) systems, allowing for secure and efficient data transfer. The platform facilitates the exchange of patient information, clinical data, and administrative data between healthcare providers, payers, and other relevant parties. Additionally, Vim's solutions help streamline healthcare workflows, such as prior authorization, referral management, and care coordination. The company also provides a platform for developers to build custom applications for core infrastructure.


The company will use the May 2021 funding for its point-of-care integration technology and continued commercial growth across health plan and provider groups throughout the country.

## Funding rounds

- Series C, Jul 1, 2021, $25M — Hong Shan, GreatPoint Ventures, Premera Blue Cross, Optum Ventures, Leverage Health
- Series C, May 5, 2021, $25M — Hong Shan, Walgreens Boots Alliance, Inc., Elevance Health, GreatPoint Ventures, Premera Blue Cross, Frist Cressey Ventures, Optum Ventures
- Series B, Aug 29, 2016, $11M — Hong Shan, GreatPoint Ventures
- Seed, Jan 1, 2015 — Hong Shan

## Investors

- Hong Shan — Seed, Series B, Series C
- GreatPoint Ventures (https://capitalatlas.ai/funds/greatpoint-ventures) — Series B, Series C
- Walgreens Boots Alliance, Inc. — Series C
- Elevance Health — Series C
- Premera Blue Cross — Series C
- Frist Cressey Ventures (https://capitalatlas.ai/funds/frist-cressey-ventures) — Series C
- Optum Ventures (https://capitalatlas.ai/funds/optum-ventures) — Series C
- Leverage Health (https://capitalatlas.ai/funds/leverage-health) — Series C